Kreon 25 000

Pancreatin, the active ingredient in Kreon 25 000, is a pancreatic enzyme preparation presented as 25000 USP lipase units per enteric‑coated capsule for oral use. It replaces deficient pancreatic enzymes and is used to manage exocrine pancreatic insufficiency in conditions such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, and after pancreatic surgery.

GNH USA supplies Kreon 25 000 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kreon 25 000 provides pancreatic enzyme replacement for disorders that cause exocrine pancreatic insufficiency.

Cystic fibrosis: improves digestion and nutrient absorption by supplying missing lipase, amylase and protease. Chronic pancreatitis: reduces steatorrhea and abdominal discomfort by supplementing pancreatic enzymes. Pancreatic cancer: aids in maintaining caloric intake when tumor impairs pancreatic function. Pancreatic resection: compensates for loss of pancreatic tissue after surgery, supporting normal digestion.

Kreon 25 000 may cause gastrointestinal and hypersensitivity reactions.

Common Side Effects: - Abdominal discomfort or cramping - Flatulence or bloating - Oily, foul‑smelling stools - Nausea or vomiting - Diarrhea - Mild abdominal pain

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute pancreatitis exacerbation - Severe abdominal pain with vomiting - Intestinal obstruction or blockage - Stevens‑Johnson syndrome or severe skin rash - Hypersensitivity with respiratory distress

Before prescribing Kreon 25 000, consider the following safety measures.

Dose adjustment: required in patients with significant renal or hepatic impairment. Monitoring: regularly assess nutritional status, weight gain and stool characteristics. Allergy: avoid in individuals with known hypersensitivity to porcine proteins. Pregnancy: safety not established; use only if potential benefit justifies the risk. Drug interactions: antacids or acid‑suppressing agents may reduce enzyme activity. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Kreon 25 000 can interact with other medications that affect gastric acidity or enzyme activity.

Major Interactions (Avoid): - Proton pump inhibitors: may reduce activation of enteric‑coated enzymes. - Antacids containing aluminum or magnesium: can bind enzymes and diminish efficacy.

Moderate Interactions (Monitor Closely): - Oral corticosteroids: may increase risk of gastrointestinal irritation. - Lipase inhibitors (e.g., orlistat): may compete for substrate and alter digestion. - Broad‑spectrum antibiotics: changes in gut flora could affect enzyme function.